Walleye Trading LLC Cara Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $4,440 - $6,385	500 New	500 $5,000
Q2 2022 Aug 08, 2022	SELL	$7.45 - $13.84 $79,715 - $148,088	-10,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $37,772 - $48,070	3,800 Added 55.07%	10,700 $130,000
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $19,184 - $29,024	1,600 Added 30.19%	6,900 $84,000
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $61,215 - $85,118	5,300 New	5,300 $82,000

Q2 2020 Aug 14, 2020	SELL	$12.39 - $17.33 $148,680 - $207,959	-12,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $109,439 - $213,360	12,000 New	12,000 $159,000
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $891,072 - $1.09 Million	-50,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $582,164 - $793,456	40,400 Added 404.0%	50,400 $989,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $290,085 - $546,851	-23,300 Reduced 69.97%	10,000 $130,000
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $33,383 - $45,505	-1,900 Reduced 5.4%	33,300 $798,000
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $408,320 - $678,304	35,200 New	35,200 $674,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.